Medley is taking shape at the corner of McGinnis Ferry Road and Johns Creek Parkway. Along with office space, it will have ...

The richest new heir this year is Marilyn Simons, the widow of hedge fund mogul Jim Simons. She is now credited with an ...

Boehringer Ingelheim subsidiary NBE Therapeutics has opened its new antibody-drug conjugates (ADC) research and development ...

Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 ...

Boehringer Laboratory Illustrative image Number of patients reached in 2024 jumps 8% to 66 million R&D investments rise to ...

Nearly three-quarters of the world’s billionaires are between the ages of 50 and 79. Just 12% are under 50. The rarest of all ...

Boehringer Ingelheim, a biopharmaceutical firm that manufactures medicine for humans and animals, has relocated to a ...

NBE Therapeutics (NBE) a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel ...

Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and guidance for this year. | Boehringer ...

Boehringer Ingelheim is pumping funds into the still-hot antibody-drug conjugate space, committing 27 million Swiss francs ...

Basel, Switzerland Friday, April 4, 2025, 10:00 Hrs [IST] ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...